Detalhe da pesquisa
1.
SAMHD1 expression contributes to doxorubicin resistance and predicts survival outcomes in diffuse large B-cell lymphoma patients.
NAR Cancer
; 6(1): zcae007, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38406263